ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.
Amrutanjan Health Care Limited submitted its 89th Annual Report for the financial year 2025-26. The company scheduled its Annual General Meeting for September 23, 2026.
Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.
Amrutanjan Health Care Limited has fixed September 11, 2026, as the record date for the payment of the final dividend for the financial year 2025-26.
Amrutanjan Health Care Ltd reported revenue from operations of ₹103 Cr (+9.6% YoY) and net profit of ₹4.4 Cr (-47.0% YoY) for Q1 FY27.
Amrutanjan Health Care Ltd explained a delay in filing a credit rating disclosure due to the unavailability of the Key Managerial Personnel.
Amrutanjan Health Care Limited has scheduled a Board meeting on August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Amrutanjan Health Care has commenced commercial operations at its new Greenfield Sanitary Napkin Manufacturing Facility in Telangana. This marks a significant manufacturing capacity expansion.
Amrutanjan Health Care has commissioned a new ₹150 crore greenfield sanitary napkin manufacturing facility in Telangana. The plant features a 700 million annual unit capacity.
CARE Ratings has assigned a 'CARE A; Stable' issuer rating to Amrutanjan Health Care Limited. The rating reflects the company's established brand and debt-free capital structure.
DSP Mutual Fund schemes sold 2,11,361 shares of Amrutanjan Health Care Limited in the open market. This transaction reduced their stake from 3.55% to 2.82%.
Amrutanjan Health Care paid ₹9.75 Crore as lease rent arrears to Kapaleeswarar Temple, complying with a Madras High Court order.
Amrutanjan Health Care filed a SEBI DP Regulation 74(5) compliance certificate confirming dematerialisation and cancellation of securities for Q1 2026. No financial impact.
Mr. Ramaswami Krishnan assumed various committee roles following Mr. Raja Venkataraman's cessation. The update ensures continuity in board-level oversight and committee governance.
Amrutanjan Health Care announced the tenure completion of Independent Director Mr. Raja Venkataraman. This board departure follows the expiration of his scheduled appointment term.
Amrutanjan Health Care issued a Postal Ballot Notice for director appointments. Shareholders will vote via e-voting between May 19 and June 18, 2026.
Amrutanjan Health Care issued a postal ballot notice for appointing and re-appointing independent directors. Shareholders can vote via e-voting from May 19 to June 18, 2026.
Amrutanjan reported a ₹57.92 Crore net profit for FY26. The board also recommended a final dividend of ₹2.90 per equity share for shareholders.
Amrutanjan reported 11.23% revenue growth for FY26 with significant 37.2% jump in Q4 profit before exceptional items. Strategy focuses on power brands, distribution expansion, and digitization.
Amrutanjan reported FY26 net sales of ₹502.55 Cr (up 11.23%) and PAT of ₹57.92 Cr (up 13.95%). Strategy focuses on expanding Pain Management, Women's Hygiene, and new Personal Care categories.
Amrutanjan Health Care approved granting 2,00,000 stock options at ₹502.00 per share to 44 employees. The scheme involves a ₹10.04 Crore equity allocation over five years.
Amrutanjan Health Care appointed Mr. Ramaswami Krishnan and re-appointed Mr. Muralidharan Swayambunathan as Independent Directors. Both appointments are for five-year terms, strengthening board governance.
Amrutanjan Health Care recommended a final dividend of ₹2.90 per share for FY 2025-26. The record date will be finalized later following shareholder approval.
Amrutanjan Health Care Ltd reported revenue from operations of ₹149.8 Cr (+10.6% YoY) and net profit of ₹16.2 Cr (+6.6% YoY) for Q4 FY26.
Amrutanjan Health Care reported FY26 financial results and recommended a ₹2.90 dividend per share. The board also appointed new independent directors and internal auditors.
Amrutanjan Health Care Ltd will hold a Board Meeting on May 8, 2026, to approve audited financial results for the year ended March 31, 2026, and recommend a final dividend for FY2025-26. The trading window remains closed until May 10, 2026.
Amrutanjan Health Care Limited has scheduled a Board Meeting for May 08, 2026. The board will consider audited standalone yearly financial results for the period ended March 2026 and a proposal for a final dividend. The trading window is closed from April 01, 2026, until May 10, 2026.